DarioHealth (NASDAQ:DRIO) Releases Earnings Results, Misses Expectations By $0.33 EPS

DarioHealth (NASDAQ:DRIO) released its quarterly earnings data on Thursday. The company reported ($2.96) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.63) by ($0.33), Zacks reports. DarioHealth had a negative return on equity of 65.89% and a negative net margin of 162.73%.The firm had revenue of $5.01 million for the quarter, compared to analysts’ expectations of $5.67 million.

DarioHealth Stock Performance

Shares of DRIO stock traded down $1.57 during mid-day trading on Thursday, hitting $10.18. The stock had a trading volume of 28,869 shares, compared to its average volume of 34,499. The firm has a market cap of $23.16 million, a PE ratio of -0.77 and a beta of 1.19. The company’s 50-day simple moving average is $12.57 and its 200-day simple moving average is $12.76. The company has a debt-to-equity ratio of 0.48, a current ratio of 3.30 and a quick ratio of 2.83. DarioHealth has a fifty-two week low of $5.93 and a fifty-two week high of $31.00.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on DRIO shares. Wall Street Zen raised DarioHealth to a “sell” rating in a research report on Saturday, October 11th. Weiss Ratings restated a “sell (e+)” rating on shares of DarioHealth in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, DarioHealth currently has a consensus rating of “Hold” and an average target price of $40.00.

Hedge Funds Weigh In On DarioHealth

A hedge fund recently raised its stake in DarioHealth stock. XTX Topco Ltd grew its holdings in DarioHealth Corp. (NASDAQ:DRIO) by 229.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,511 shares of the company’s stock after buying an additional 43,513 shares during the quarter. XTX Topco Ltd owned about 0.14% of DarioHealth worth $42,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 33.39% of the company’s stock.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.